Related Experiment Video
Updated: Jun 29, 2026

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5
Kazuo Fushimi1, Payal Ray, Amar Kar
1Department of Neurology, Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, 303 East Superior Street, Chicago, IL 60611, USA.
Abstract:
Similar to many genes involved in programmed cell death (PCD), the caspase 2 (casp-2) gene generates both proapoptotic and antiapoptotic isoforms by alternative splicing. Using a yeast RNA-protein interaction assay, we identified RBM5 (also known as LUCA-15) as a protein that binds to casp-2 pre-mRNA. In both transfected cells and in vitro splicing assay, RBM5 enhances the formation of proapoptotic Casp-2L. RBM5 binds to a U/C-rich sequence immediately upstream of the previously identified In100 splicing repressor element. Our mutagenesis experiments demonstrate that RBM5 binding to this intronic sequence regulates the ratio of proapoptotic/antiapoptotic casp-2 splicing isoforms, suggesting that casp-2 splicing regulation by RBM5 may contribute to its tumor suppressor activity. Our work has uncovered a player in casp-2 alternative splicing regulation and revealed a link between the alternative splicing regulator and the candidate tumor suppressor gene. Together with previous studies, our work suggests that splicing control of cell death genes may be an important aspect in tumorigenesis. Enhancing the expression or activities of splicing regulators that promote the production of proapoptotic splicing isoforms might provide a therapeutic approach to cancer.
Insights
The protein RBM5 binds to caspase 2 (casp-2) pre-mRNA, promoting the proapoptotic Casp-2L isoform. This splicing regulation by RBM5 may contribute to its tumor suppressor activity and offers potential cancer therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Biology
- RNA Splicing
Background:
- Alternative splicing of caspase 2 (casp-2) generates proapoptotic and antiapoptotic isoforms.
- Programmed cell death (PCD) regulation is crucial in cancer development.
Purpose of the Study:
- To identify proteins that regulate casp-2 alternative splicing.
- To investigate the role of RBM5 in casp-2 splicing and its potential tumor suppressor function.
Main Methods:
- Yeast RNA-protein interaction assay to identify RBM5 binding to casp-2 pre-mRNA.
- Transfected cell and in vitro splicing assays to assess RBM5's effect on splicing.
- Mutagenesis experiments to map RBM5 binding sites and functional consequences.
Main Results:
- RBM5 was identified as a protein that binds to casp-2 pre-mRNA.
- RBM5 enhances the production of the proapoptotic Casp-2L isoform.
- RBM5 binds to a specific intronic sequence, regulating the ratio of casp-2 splicing isoforms.
Conclusions:
- RBM5 is a novel regulator of casp-2 alternative splicing.
- RBM5-mediated splicing control of casp-2 may contribute to tumor suppression.
- Targeting splicing regulators like RBM5 could offer new cancer therapies.
Related Concept Videos
Caspases
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
RNA Splicing
Negative Regulator Molecules
